Skip to Content

Croda International PLC

CRDA: XLON (GBR)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
GBX 5,579.00FsqwrskXzdqtlmck

Croda's Well-Positioned Drug Delivery Portfolio Should Drive Strong Growth

Business Strategy and Outlook

Croda is a British specialty chemicals company focused on the consumer, crop protection, and healthcare end markets. Croda targets fast-growing niches across these industries, looking to consolidate its presence by acquiring early-stage technology and science-rich firms and becoming entrenched in the supply chain of its customers through its high-touch direct selling model and a strong focus on collaborative innovation. A key driver for the company is the percentage of sales from new and protected products, or NPPs, which represented around 35% of group sales in 2022.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CRDA so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center